The largest database of trusted experimental protocols

9 protocols using cd45ra pe cy5

1

Monitoring T Cell Proliferation and Subset Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were stimulated with anti-CD3 mAb (OKT3) plus CD28, or mixed in a 1:1 ratio with irradiated allogeneic DCs in mixed lymphocyte reaction (MLR) as described (18 (link)). To determine cell proliferation, T cells were labeled with CFSE and cell division was monitored by using the FITC channel in a FACScanto II flow cytometer (BD Biosciences). Aliquots of PBMCs were analyzed by 7-color flow cytometry using a panel of surface molecule specific antibodies: CD4-APC (5 ug/ml), CD8-Pacific Blue (5 ug/ml), CD62L-APC/Cy7 (5 ug/ml), CD45RA-PE/Cy5 (2.5 ug/ml) and CD45RO-PE/Cy7 (2.5 ug/ml) (BD Pharmingen, San Jose, CA). Analyses of CD8+ T cell subsets were determined by assessing CD45RA and CD62L surface markers.
+ Open protocol
+ Expand
2

Flow Cytometric Analysis of Lymphocyte Phenotypes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cryopreserved PBMCs collected at T0 and T12 were thawed and stained (1x106 cells) with fluorochrome-labelled antibodies for the flow cytometric study of lymphocyte surface phenotypes. To check cell viability, cells were stained with 7-aminoactynomycin D (7-AAD, BD Biosciences, San Jose, California, USA) for 30 min in the dark at 4°C. Only samples with cellular viability greater than 70% were used for experiments.
The following antibodies were used: HLA-DR-FITC, CD38-PE, CCR7-PeCy7, CD45RA-PeCy5, CD27-PE, CD95-APC, α4β7integrin-APC CCR6-PeCy7, CD161-APC (BD Biosciences, San Jose, California, USA), CCR9-FITC (R&D Systems, Minneapolis, MN, USA).
We evaluated CD4+ and CD8+ activation (HLA-DR+CD38+), maturation (naïve: CCR7+CD45RA+; central memory: CCR7+CD45RA-; effector memory: CCR7-CD45RA-; terminally differentiated: CCR7-CD45RA+) and stem cell-like memory T cells (Tscm; CCR7+CD45RA+CD27+CD95+). CD4+ T-cell populations involved in mucosal immunity (CCR9+α4β7+; CCR6+CD161+) were also studied.
Cells were run on a FACS VERSE cytometer (BD Biosciences, San Jose, California, USA).
+ Open protocol
+ Expand
3

Multiparametric Flow Cytometry of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMC were thawed in warm media, washed twice and stained with three separate antihuman antibody cocktails containing: (1 ) anti-CD3 AmCyan, CD4 Pacific Blue, CD8 APCH7, CD28 APC; (2 ) CD3 AmCyan, CD4 Pacific Blue, CD8 APCH7, CD27 PE, CD45RA PE-Cy5; (3 (link)) CD3 AmCyan, CD19 Alexa Fluor700, CD56 PE, CD33 PE-Cy7, TCR APC, all reagents from BD Biosciences. Additional information for these antibodies can be found on ImmPort (https://immport.niaid.nih.gov/) under accession number SDY212. Incubation with antibodies was performed for 40 min at 4ºC. Cells were washed with FACS buffer (PBS supplemented with 2% FBS and 0.1% Na Azide), and resuspended in 200 µL FACS buffer. Data was collected using DIVA software in an LRSII instrument (BD Biosciences). Analysis was performed using FlowJo 8.8.6 by gating on live cells based on forward vs side scatter profiles, then using double gating for singlet discrimination, followed by cell subset-specific gating.
+ Open protocol
+ Expand
4

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were surface stained, fixed, and refrigerated at 4°C overnight, followed by flow cytometry using the BD LSRII instrument according to manufacturer’s protocols (BD Biosciences, Carlsbad, CA, USA). An 11-color flow panel of cross-reactive antibodies was used: CD3 Alexa700, CD4 BD-V500, CD8 BD-V450, CD20 FITC, CCR5 PE, CXCR4 PE-CF594, CCR7 PE-Cy7, CD45RA PE-Cy5, CD14 APC, CD69 APC-H7, and HLA-DR BV605 (BD Biosciences). Samples were analyzed using FlowJo (TreeStar Inc, Ashland, OR, USA), and results graphed using GraphPad Prism 5 (Graphpad Software Inc, La Jolla, CA, USA).
+ Open protocol
+ Expand
5

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh PBMCs were stained with anti-CD3-APC-Cy7, CD8-APC, CD45RA-PE-Cy5, CCR7-PE-Cy7, PD-1-Pacific Blue, IL-7Rα-FITC, CD27-PE, CD28-PE, CTLA4-PE, CX3CR1-PE antibodies or isotype control (all from BioLegend, San Diego, CA). PBMCs that had been stimulated with PMA/ionomycin were stained with anti-CD3-APC-Cy7, CD8-APC, CD45RAPE-Cy5 and CCR7-PE-Cy7 antibodies followed by fixation, permeabilization (Cytofix/Cytoperm Kit, BD Biosciences) and staining with anti-IFNγ-PE, TNF-α-FITC or IL-13-PE antibodies (BioLegend).14 (link) Stained cells were analyzed on an LSRII® flow cytometer (BD Biosciences). Collected data were analyzed using FlowJo software (Tree Star, Ashland, OR).
+ Open protocol
+ Expand
6

Flow Cytometry Analysis of Immune Cells from Spleen and Aorta

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rats were euthanized under anesthesia and single cell suspensions from spleens were obtained by disaggregating spleen tissue between frosted glass microscopy slides. Erythrocytes were lysed by suspending splenocytes pellets in a hypotonic solution (155 mM NH4Cl, 12 mM NaHCO3, 0.1 mM EDTA), nucleated cells were washed twice with phosphate buffered saline (PBS). Flow cytometry was performed as described earlier (Singh et al., 2017 (link)). Briefly, washed splenocytes were suspended in Fc blocking buffer (2% v/v fetal bovine serum and 1% v/v normal mouse serum in PBS). An aliquot of 106 cells was taken from each sample and mixed with FITC-CD161, PerCP-CD8a, APC-CD4, PE-CD3, and PE-Cy5-CD45RA antibodies (1 μl each antibody, all antibodies from BD Biosciences). After incubation with antibodies on ice for 30 min, cells were washed twice with PBS and resuspended in 400 μl PBS and flow cytometry was performed on a Beckton-Dickinson Aria flow cytometer. Thoracic aorta were minced with a razor blade and digested in 0.05% w/v Collagenase Type I and 0.05% w/v Collagenase Type II in HBSS. Cells were dissociated by trituration and filtered through a nylon membrane followed by two washes with ice cold PBS. Cells were then processed as described above for the spleen cells.
+ Open protocol
+ Expand
7

Phenotyping Peripheral CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Approximately 500 μL of venous blood was obtained and stained with mouse anti-human (APC CD3, BD PharmingenTM Cat.555335; FITC CD4, BD PharmingenTM Cat.555346; and PE-Cy™5 CD45RA, BD PharmingenTM Cat.555490) antibodies. Briefly, venous blood was diluted with an equal volume of plain RPMI-1640 media and aliquots of 100μL were pipetted into snap-cap tubes. The blood-media mixture was then stained with 10 μL of fluorochromed surface antibodies and incubated at 4°C for 30 minutes. The red blood cells (RBCs) were then lysed using cold 1X BD Pharm LyseTM lysing buffer (Cat.555899) at room temperature for 10 minutes. The cells were washed twice in cold wash buffer (5g Bovine serum albumin (BSA) + 0.5g Sodium azide in 500mL Phosphate buffered saline (PBS)) and fixed in 1% paraformaldehyde at 4°C. Cells were then acquired using a four-color FACSCalibur within 24 hours of staining. Lymphocytes were acquired and stored on gate R1 (Fig 1A). These were further gated as CD4+ and CD4- lymphocytes as shown in Fig 1B. In order to determine the proportion of CD4+ lymphocytes that were T cells, a third gate for CD3+ was used (Fig 1C). This gate demonstrated that ~98.0% (median value) of the CD4+ lymphocytes were (CD3+) T cells.
+ Open protocol
+ Expand
8

Characterization of Human CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mononuclear cells were prepared from peripheral blood on Ficoll‐Paque (GE Healthcare) gradients as previously done (Shin et al., 2015). Peripheral blood mononuclear cells (PBMCs) were labeled with antibodies to APC‐cyanin 7 (Cy7)‐CD3, Pacific Blue–CD8α, PE–Cy5–CD45RA, PE‐Cy7‐CCR7 (all from BD Biosciences), FITC‐IL‐7Rα (R&D Systems), and PE‐CX3CR1 (BioLegend). Some cells were fixed and permeabilized using Cytofix/Cytoperm solution (BD Biosciences) and additionally stained with antibodies to PE‐FGFBP2, PE‐GZMB, and biotinylated GZMH (all from R&D Systems). Biotinylated GZMH antibodies were then labeled with Pacific Blue conjugated anti‐goat IgG (Biolegend) secondary antibodies. Stained cells were analyzed using an LSRII® flow cytometer (BD Biosciences) and FlowJo software (TreeStar). For FACS sorting of IL‐7Rαlow and high EM CD8+ T cells, freshly isolated PBMCs were stained with antibodies to APC‐Cy7‐CD16, Pacific Blue–CD8α, PE–Cy5–CD45RA, PE‐Cy7‐CCR7, and FITC‐IL‐7Rα antibodies. Stained cells were sorted into IL‐7Rαlow and high EM (CCR7) CD8+ T cells using a FACSAria® (BD Biosciences). The purity of cells was >97%.
+ Open protocol
+ Expand
9

Multiparameter Flow Cytometry Analysis of Immune Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mononuclear cells were prepared from peripheral blood on FicollPAQUE (GE Healthcare, Piscataway, NJ) gradients. Peripheral blood mononuclear cells (PBMCs) were labeled with antibodies to APC-cyanin (Cy)-CD3, Pacific Blue–CD8α, PE–Cy5–CD45RA, PE-Cy7-CCR7 (all from BD Biosciences, San Diego, CA), IL-7Rα antibodies (R&D Systems, Minneapolis, MN) and PE-CX3CR1, PE-CXCR1 or PE-CXCR6 (BioLegend, San Diego, CA). Unconjugated IL-7Rα antibodies were labeled with FITC conjugated anti-goat IgG (Santa Cruz Biotechnology, Santa Cruz, CA) secondary antibodies. Some cells were fixed, permeabilized using Cytofix/Cytoperm solution (BD Biosciences), and additionally labeled with antibodies to PE-CCL3, PE-CCL4 or PE-CCL20 (all from R&D Systems). Labeled cells were analyzed using an LSRII® flow cytometer (BD Biosciences) and FlowJo software (TreeStar, Ashland, OR).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!